Author

Yelena Z. Ginzburg

Tisch Cancer InstituteORCID 0000-0002-3496-3783Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Anisa Azatovna GumerovaiD· 2 shared Georgii PevneviD· 2 shared Mone ZaidiiD· 2 shared Tony YueniD· 2 shared Alessandro Principi· 1 shared Althea Agdamag· 1 shared C Yang· 1 shared Christoph SchanieliD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anisa Azatovna GumerovaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Linezolid Acts as a Selective Inhibitor of the JAK2V617F Mutation

Anisa Azatovna Gumerova, Christoph Schaniel, Zixing Huang, Althea Agdamag, Shuhui Liu, Alessandro Principi, Jacob S. Kazmi, Francisco Fueyo‐González, Cui J, Georgii Pevnev, C Yang, Zehra Berna Tumoglu, Xin Gao, Tony Yuen, Yelena Z. Ginzburg, , H C Li

This paper shows linezolid selectively inhibits JAK2V617F mutant cells in PV models, reducing disease burden without affecting wild-type cells.

bioRxiv · Jun 3, 2026 · PreprintCancer Biology

Erythroferrone Modulates Osteoblast-Osteoclast Crosstalk During Bone Remodeling

Pinanong Na-Phatthalung, Gabrielle van Caloen, Marina Planoutene, Emily Tai, Anisa Azatovna Gumerova, Georgii Pevnev, Jay Cao, Ronit Witztum, Eva Ingber, Léon Kautz, Farhath Sultana, Funda Korkmaz, Maayan Levy, Tony Yuen, Mone Zaidi, Yelena Z. Ginzburg

This study shows that osteoclast-derived erythroferrone (ERFE) regulates bone mass by modulating osteoblast-osteoclast communication, with ERFE loss in osteoclasts leading to increased osteoclastogenesis and bone loss.

bioRxiv · May 8, 2026 · PreprintCell Biology